Concepedia

Ma Teresa Cibeira

MT

Statistics

Publications

10

Citations

990

H-Index

10

Active since

2004

Affiliations

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer(Current)

Hospital Clínic de Barcelona

Universitat de Barcelona

Hospital Universitario de La Princesa

Complejo Hospitalario de Salamanca

Ma Teresa Cibeira is an author at Consorci Institut D'Investigacions Biomediques August Pi I Sunyer specializing in hematology, pathology, and medicine.

Top concepts

Publications per year

2004–2022

10

Publications

10

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

Laura Rosiñol, Albert Oriol, Ana Isabel Teruel et al. · Blood · 2012 · 485 citations · Full text

Extramedullary multiple myeloma escapes the effect of thalidomide.

Laura Rosiñol, Ma Teresa Cibeira, Joan Bladé et al. · PubMed · 2004 · 135 citations

Bortezomib: an effective agent in extramedullary disease in multiple myeloma

Laura Rosiñol, Ma Teresa Cibeira, Carla Uriburu et al. · European Journal Of Haematology · 2006 · 127 citations

Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression

Carlos Fernández de Larrea, Ignacio Isola, Arturo Pereira et al. · Leukemia · 2018 · 63 citations

, , +9

Thalidomide / Dexamethasone (TD) Vs. Bortezomib (Velcade)a/Thalidomide / Dexamethasone (VTD) Vs. VBMCP/VBAD/Velcadea as Induction Regimens Prior Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): Results of a Phase III PETHEMA/GEM Trial.

Laura Rosiñol, Ma Teresa Cibeira, Joaquín Martínez‐López et al. · Blood · 2009 · 44 citations

1–5 of 10